Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials

INTRODUCTION: Patients with moderate-to-severe atopic dermatitis (AD) report a multidimensional disease burden that includes impaired health-related quality-of-life (HRQoL). Changes in overall health status and specific dimensions that contribute to HRQoL were evaluated in adults with moderate-to-se...

Descripción completa

Detalles Bibliográficos
Autor principal: Simpson, Eric L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453923/
https://www.ncbi.nlm.nih.gov/pubmed/28503712
http://dx.doi.org/10.1007/s13555-017-0181-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453923/
https://www.ncbi.nlm.nih.gov/pubmed/28503712
http://dx.doi.org/10.1007/s13555-017-0181-6

Ejemplares similares